News
Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 34.9% in the pre-market session after Novo Nordisk ...
In essence, Hims & Hers is embracing a "if you can't beat 'em, join 'em" approach that gives their customers more options.
Novo Nordisk said on Tuesday it was working with telehealth firms Hims & Hers, Ro and LifeMD to sell Wegovy, as it looks to ...
Hims & Hers ( HIMS) stock popped more than 20% in trading early Tuesday after Novo Nordisk ( NVO) announced a partnership with it and other telehealth platforms to offer patients access to the ...
A batch of the drug is under a limited voluntary recall after a shipping error exposed certain doses to improper temperatures.
It pains me to think I won’t be able to fully see my grandchildren’s faces and fully experience the biggest moments of my ...
Deals with Hims & Hers, LifeMD and Ro following a court's dismissal of a lawsuit challenging the FDA's determination Wegovy ...
Novo Nordisk and a popular virtual health company are making Wegovy more accessible to millions of more Americans. Hims & ...
Canada's Royal Bank of Canada will abandon its sustainable finance goals as industry practices for measuring and reporting ...
Shares of online health platform Hims & Hers Health soared Tuesday after the company announced a partnership with Novo ...
The stock (HIMS) soared 24.2% in midday trading toward a one-month closing high. It's on track the biggest one-day gain since it ran up 27.7% on Feb. 13, 2025. That rally was part of a big surge to ...
Hims & Hers partners with Novo Nordisk to offer Wegovy access online with clinical support, expanding its weight loss care and revenue strategy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results